|
1
|
Selby C: Sex hormone binding globulin:
Origin, function and clinical significance. Ann Clin Biochem.
27:532–541. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mousavi Y and Adlercreutz H: Genistein is
an effective stimulator of sex hormone-binding globulin production
in hepatocellular carcinoma human liver cancer cells and suppresses
proliferation of these cells in culture. Steriods. 58:301–304.
1993. View Article : Google Scholar
|
|
3
|
Sawada N, Iwasaki M, Inoue M, Sasazuki S,
Yamaji T, Shiazu T and Tsugane S; Japan Public Health Center-based
Prospective Study Group, : Plasma testosterone and sex
hormone-binding globulin concentrations and the risk of prostate
cancer among Japanese men: A nested case-control study. Cancer Sci.
101:2652–2657. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garcia-Closas M, Brinton LA, Lissowsk J,
Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch
R, Yeager M, Zatonski W and Chanock SJ: Ovarian cancer risk and
common variation in the sex hormone binding globulin gene: A
population-based case-control study. BMC Cancer. 7:602007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grasso M, Buonaguidi A, Mondina R,
Borsellino G, Lania C, Banfi G and Rigatti P: Plasma sex hormone
binding globulin in patients with prostatic carcinoma. Cancer.
66:354–357. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salonia A, Briganti A, Gallina A,
Karakiewicz P, Shariat S, Freschi M, Zann G, Caoitanio U, Bosi E,
Rigatti P and Montorsi F: Sex hormone-binding globulin: A novel
marker for nodal metastases prediction in prostate cancer patients
undergoing extended pelvic lymph node dissection. Urology.
73:850–855. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haapianen R, Rannikko S, Adlercreutz H and
Alfthan O: Correlation of pretreatment plasma levels of estradiol
and sex-hormone binding globulin-binding capacity with clinical
stage and survival of patients with prostate cancer. The Prostate.
8:127–137. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calciano A, Khaw KT, Barrett-Connor E and
Garland C: Sex hormones, sex hormone binding globulin, and lung
cancer: A 12 year prospective study in a cohort of malesaged 50-79.
Br Med J. 296:16401988. View Article : Google Scholar
|
|
9
|
Corbishley TP, Keating JJ, Johnson PJ and
Williams R: Serum concentrations of sex hormone binding globulin in
lung cancer. Br Med J. 293:792–793. 1986. View Article : Google Scholar
|
|
10
|
Fortunati N, Catalano MG, Boccuzzi G and
Fairia R: Sex hormone binding globulin, estradiol and breast
cancer. Mol Cell Endocrinol. 316:86–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dayalu NSL, Suresh H, Anil KB, Renuka S,
Sudershan K and Amitabha R: Sex hormone binding globulin in breast
cancer. Indian J Clin Biochemist. 23:25–254. 2008.
|
|
12
|
Catalano MG, Frairia R, Boccuzzi G and
Fortunati N: Sex hormone-binding globulin antagonizes the
anti-apoptotic effect of estradiol in breast cancer cells. Mol Cell
Endocrinol. 230:31–37. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ratajczak T, Twaddle E and Hähnel R: Sex
hormone-binding globulin and estrogen receptor in endometrial and
cervical cancer. Gynecol Oncol. 10:262–266. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moore JW, Key TJ, Clark GM, Bulbrook RD,
Allen DS, Wang DY and Pike MC: Concentrations of sex
hormone-binding globulin (SHBG) in a population of normal females:
Relationship to risk factors for breast cancer. Steroids.
52:391–392. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adami HO, Johansson EDB, Vegelius J and
Victor A: Serum concentrations of estrone, androstenedione,
testosterone and sex hormone-binding globulin in postmenopausal
females with breast cancer and in age-matched controls. Upsala J
Med Sci. 84:259–274. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moore JW, Clark GM, Bulbrook RD, Hayward
JL, Murai JT, Hammond GL and Siiteri PK: Serum concentrations of
total and non-protein-bound estradiol in patients with breast
cancer and on normal controls. Int J Cancer. 29:17–21. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toniolo PG, Levitz M, Zeleniuch-Jacquotte
A, Banerjee S, Koenig KL, Shore RE, Strax P and Pasternack BS: A
prospective study of endogenous estrogens and breast cancer in
postmenopausal females. J Natl Cancer Inst. 87:190–197. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeleniucg-Jacquotte A, Shore RE, Koenig
KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks
R and Toniolo P: Postmenopausal levels of estrogen, androgen, and
SHBG and breast cancer: Longterm results of a prospective study. Br
J Cancer. 90:153–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lipworth L, Adami HO, Trichopoulos D,
Carlstrom K and Mantzoros C: Serum steroid hormone levels,
sex-hormone binding globulin and body mass index in the etiology of
postmenopausal breast cancer. Epidemiology. 7:96–100. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murayama Y, Utsunomiya J, Takahashi I,
Kitamura M and Tominaga T: Sex hormone binding globulin as a
reliable indicator of hormone dependence in human breast cancer.
Ann Surg. 190:133–138. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakai F, Cheix F, Clavel M, Colon J, Mayer
M, Pommatau E and Saez S: Increases in steroid binding globulins
induced by tamoxifen in patients with carcinoma of the breast. J
Endocrinol. 76:219–226. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang DY, Rubend RD, Clark GMG, Moore JW
and Bulbrook RD: Effects of prednisolone on sex hormone binding
globulin during primary endocrine treatment of advanced breast
cancer. Breast Cancer Res Treat. 11:67–70. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beattie MS, Costantino JP, Cummings SR,
Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark
N and Hankinson SE: Endogenous sex hormones, breast cancer risk,
and tamoxifen response: An ancillary study in the NSABP Breast
Cancer Prevention Trial (P-1). J Natl Cancer Inst. 98:110–115.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kattan MW: Judging new markers by their
ability to improve predictive accuracy. J Natl Cancer Inst.
95:634–635. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rha SY, Yang WI, Gong SJ, Kim JJ, Yoo NC,
Roh JK, Min JS, Lee KS, Kim BS and Chung HC: Correlation of tissue
and blood plasminogen activation system in breast cancer. Cancer
Lett. 150:137–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park HA, Park JK, Park SA and Lee JS: Age,
menopause, and cardiovascular risk factors among Korean middle-aged
women: The 2005 Korea National Health and Nutrition Examination
Survey. J Womens Health (Larchmt). 19:869–876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing. (Vienna). 2012.http://www.R-project.org/
|
|
28
|
RStudio Team, . RStudio: Integrated
development for R. RStudio, Inc. (Boston, MA). 2019.http://www.rstudio.com/
|
|
29
|
Lee SE, Chung JS, Han BK, Park CS, Moon
KH, Byun SS, Choe GY and Hong SK: Pre-operative serum sex
hormone-binding globulin as a predictive marker for extra-prostatic
extension of tumor in patients with clinically localized prostate
cancer. Eur J Urol. 54:1324–1332. 2008. View Article : Google Scholar
|
|
30
|
Nunzio CD, Lombardo R, Albisinni S, Gacci
M and Tubaro A: Serum levels of sex hormone binding globulin (SHBG)
are not predictive of prostate cancer diagnosis and aggressiveness:
results from an Italian biopsy cohort. Int Braz J Urol. 39:793–799.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moore JW, Key TJA, Bulvrook RD, Clark GMG,
Allen DS, Wang DY and Pike MC: Sex hormone binding globulin and
risk factors for breast cancer in a population of normal females
who had never used exogenous sex hormones. Br J Cancer. 56:661–666.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pugeat M, Cousin P, Baret C, Lejeune H and
Forest MG: Sex hormone-binding globulin during puberty in normal
and hyperandrogenic girls. J Pediatr Endocrinol Metab. 13
(Suppl):1277–1279. 2000.PubMed/NCBI
|
|
33
|
Plymate SR, Stutz FH and Fariss BL:
Relationship between sex hormone-binding globulin and estrogen
receptors in breast cancer. J Clin Oncol. 2:652–654. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He XY, Liao YD, Zhang Y and Wang R: Sex
hormone binding globulin and risk of breast cancer in
postmenopausal females: A meta-analysis of prospective studies.
Horm Metab Res. 47:485–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim Z, Min SY, Yoon CS, Lee HJ, Lee JS,
Youn HJ, Park HK, Noh DY and Hur MH; Korean Breast Cancer Society,
: The basic facts of Korean breast cancer in 2011: Results of a
nationwide survey and breast cancer registry database. J Breast
Cancer. 17:99–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fortunati N, Becchis M, Catalano MG, Comba
A, Ferrera P, Raineri M, Berta L and Frairia R: Sex hormone-binding
globulin, its membrane receptor, and breast cancer: A new approach
to the modulation of estradiol action in neoplastic cells. J
Steroid Biochem Mol Biol. 69:473–479. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dimou NL, Papadimitriou N, Gill D,
Christakoudi S, Murphy N, Gunter MJ, Travis RC, Key TJ, Fortner RT,
Haycock PC, et al: Sex hormone binding globulin and risk of breast
cancer: A Mendelian randomization study. Int J Epidemiol.
48:807–816. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou JY, Shi R, Yu HL, Zheng WL and Ma WL:
Association between SHBG Asp327Asn (rs6259) polymorphism and breast
cancer risk: A meta-analysis of 10,454 cases and 13,111 controls.
Mol Biol Rep. 39:8307–8314. 2012. View Article : Google Scholar : PubMed/NCBI
|
